Similar Search Results

The Impact of EU Competition Law on National Healthcare Systems

Sauter, Wolf - 2013

Whereas the EU's internal market rules govern market access and public intervention, its competition rules are … concerned with the market conduct of private parties. When do the competition rules apply to healthcare? In principle the scope … for application of the competition rules to the healthcare sector is largely defined by the Member States themselves. This …

Persistent link: https://www.econbiz.de/10013090330

The impact of decentralisation on the performance of health care systems : A non-linear relationship

Dougherty, Sean - 2019

This paper examines the relationship between the degree of administrative decentralisation across levels of government in health care decision-making and health care spending, life expectancy as well as hospital costs. This empirical analysis builds on previous analytical research carried out by...

Persistent link: https://www.econbiz.de/10012454079

Decentralisation and performance measurement systems in health care

Beazley, Ivor - 2019

Based on an OECD survey, this paper presents quantitative and qualitative data on the decentralisation of health systems, focusing on how they vary according to different institutional characteristics and what types of performance measurement systems are used in the health sector....

Persistent link: https://www.econbiz.de/10012454522

Telemedicine and Primary Health : The Virtual Doctor Project Zambia

Mupela, Evans; Mustarde, Paul; Jones, Huw - 2014

This paper is a commentary on a project application of telemedicine to alleviate primary health care problems in Lundazi district in the Eastern province of Zambia. The project dubbed 'The Virtual Doctor Project' will use hard body vehicles fitted with satellite communication devices and modern...

Persistent link: https://www.econbiz.de/10014181591

Real convergence and the determinants of growth in EU candidate and potential candidate countries : a panel data approach

Borys, Magdalena Morgese; Polgár, Éva Katalin; Zlate, … - 2008

The EU candidate and potential candidate countries have made considerable progress in economic transition and integration into the world economy within less than two decades. Nevertheless, gaps in terms of income per capita relative to the euro area remain large. This suggests that the...

Persistent link: https://www.econbiz.de/10011641211

Growth and welfare effects of health care in knowledge based economies : conference paper

Kuhn, Michael; Prettner, Klaus - 2013

We study the effects of a labor-intensive health care sector within an R&D-driven growth model with overlapping generations. Health care increases longevity and labor participation/productivity. We examine under which conditions expanding health care enhances growth and welfare. Even if the...

Persistent link: https://www.econbiz.de/10010338973

Real convergence and the determinants of growth in EU candidate and potential canditate countries : a panel data approach

Morgese Borys, Magdalena - 2008

Persistent link: https://www.econbiz.de/10013439638

Harmonisation in Healthcare : The EU Patients’ Rights Directive

Sauter, Wolf - 2011

In the EU harmonisation of healthcare has long been elusive. Article 168 paragraph 7 TFEU even forms a sector-specific subsidiarity clause. Meanwhile the ECJ handed down a series of judgments concerning patients' rights to reimbursement for healthcare consumed in other Member States. An initial...

Persistent link: https://www.econbiz.de/10013124138

Consumer Financial Protection in Health Care

Fuse Brown, Erin C. - 2017

There are inadequate consumer protections from harmful medical billing practices that result in unavoidable, unexpected, and often financially devastating medical bills. The problem stems from increasing cost shifting to patients underway in American health care and the inordinate complexity...

Persistent link: https://www.econbiz.de/10012964746

Sharing R&D Risk in Healthcare via FDA Hedges

Jørring, Adam - 2017

The high cost of capital for firms conducting medical research and development (R&D) has been partly attributed to the government risk facing investors in medical innovation. This risk slows down medical innovation because investors must be compensated for it. We propose new and simple financial...

Persistent link: https://www.econbiz.de/10012959215

1
2
3
4
5
6
7
8
9
10
Next
Last